Stay updated with breaking news from Avacta Affimer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS...
Life sciences company Avacta has announced a second milestone equity payment increasing its shareholding in AffyXell Therapeutics, a joint venture to develop next-generation cell therapies between Avacta and Daewoong Pharmaceutical in South Korea. Click to read more...
Avacta Group PLC on Monday celebrated rapid progress on its joint venture in South Korea, following a second equity payment. The Wetherby, England-based life sciences company said that the payment... | June 5, 2023
Wetherby-based life sciences company Avacta Group has made “rapid progress” with a joint venture project in Southy Korea to develop next-generation cell therapies.
Life science company Avacta Group announced on Monday that a second milestone equity payment had been triggered, resulting in an increased shareholding for Avacta in AffyXell Therapeutics.